FMO5 and Hypertension: With our recent studies, we could demonstrate that phagocytic NADPH oxidase in circulating white blood cells is increased under chronic GTN and ISMN therapy [18, 29] and that the extent of ISMN-induced vascular complications is synergistically increased in the setting of type 1 diabetes mellitus and arterial hypertension [30, 31].